CAS 928672-86-0 Maʻemaʻe ≥99.0% (HPLC) API
| Helu CAS | 928672-86-0 |
| Helu CAT | RF-API22 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram |
| ʻĀpana Molekala | C24H27FO6S |
| Kaumaha Molecular | 462.53 |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Pauda keʻokeʻo |
| ʻIkepili | HPLC/NMR |
| Ka hikiwawe | Hiki loa i ka Methanol;Hiki ke hoʻoheheʻe ʻia i ka Ethanol, Acetonitrile;Hiki i ka wai |
| Maʻemaʻe / Kaʻina Hanana | ≥99.0% (HPLC) |
| Ka haumia o ke kanaka | ≤0.10% |
| Huina paumaele | ≤0.50% |
| Nā mea hoʻoheheʻe koena | |
| Methanol | ≤3000ppm |
| Ethanol | ≤5000ppm |
| Acetonitrile | ≤400ppm |
| Dichloromethane | ≤600ppm |
| Ethyl Acetate | ≤5000ppm |
| THF | ≤720ppm |
| Toluene | ≤890ppm |
| Kūlana hoʻāʻo | Pākē Pharmacopoeia (CP);Kūlana ʻoihana |
| Hoʻohana | Mea Hana Lapaʻau Hoʻoikaika (API);SGLT-2 inhibitors Type 2 Diabetes |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Pale mai ka malamalama, ka makū
He lāʻau ia o ka papa gliflozin a i ʻole subtype 2 sodium-glucose transport inhibitors (SGLT2) i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2.Ua hoʻomohala ʻia e Mitsubishi Tanabe Pharma a kūʻai ʻia ma lalo o ka laikini e Janssen, kahi mahele o Johnson & Johnson.ʻO ia ke kuleana no ka liʻiliʻi o 90% o ka reabsorption glucose i loko o ka puʻupaʻa.ʻO ka pale ʻana i kēia transporter e hoʻopau ʻia ka glucose koko ma o ka mimi.Ma Malaki 2013, ua lilo ia i mea hoʻopaneʻe SGLT2 mua i ʻae ʻia ma United States.Ua ʻōlelo ʻo Te haʻi i ka pōmaikaʻi, kōkua kēia lāʻau i ka poʻe maʻi e hōʻemi i ke kō koko me ka ʻole o ka hoʻonui ʻana i ka nui o ka loaʻa ʻana o ke kaumaha ke mālama ʻia ka meaʻai olakino a me ka hoʻoikaika mau.Eia kekahi, Loaʻa ka manaʻo ākea ma muli o kāna mau hopena antiobesity nui a me nā hanana hypoglycemic liʻiliʻi.
